Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Pzena Investment Management Inc is an asset management business based in the US. Pzena Investment Management shares (PZN) are listed on the NYSE and all prices are listed in US Dollars. Pzena Investment Management employs 125 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$10.48|
|52-week range||$4.70 - $12.10|
|50-day moving average||$10.33|
|200-day moving average||$10.81|
|Wall St. target price||$13.00|
|Dividend yield||$0.34 (3.22%)|
|Earnings per share (TTM)||$0.71|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||0.77%|
|1 month (2021-09-17)||8.38%|
|3 months (2021-07-16)||-3.76%|
|6 months (2021-04-16)||-4.20%|
|1 year (2020-10-16)||86.48%|
|2 years (2019-10-16)||21.30%|
|3 years (2018-10-16)||5.22%|
|5 years (2016-10-14)||36.10%|
Valuing Pzena Investment Management stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Pzena Investment Management's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Pzena Investment Management's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Pzena Investment Management shares trade at around 15x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Pzena Investment Management's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.11. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Pzena Investment Management's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Pzena Investment Management's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $85.3 million.
The EBITDA is a measure of a Pzena Investment Management's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$170.6 million|
|Operating margin TTM||49.33%|
|Gross profit TTM||$70.1 million|
|Return on assets TTM||29.94%|
|Return on equity TTM||85.7%|
|Market capitalisation||$753.1 million|
TTM: trailing 12 months
There are currently 162,554 Pzena Investment Management shares held short by investors – that's known as Pzena Investment Management's "short interest". This figure is 9.3% up from 148,774 last month.
There are a few different ways that this level of interest in shorting Pzena Investment Management shares can be evaluated.
Pzena Investment Management's "short interest ratio" (SIR) is the quantity of Pzena Investment Management shares currently shorted divided by the average quantity of Pzena Investment Management shares traded daily (recently around 40537.157107232). Pzena Investment Management's SIR currently stands at 4.01. In other words for every 100,000 Pzena Investment Management shares traded daily on the market, roughly 4010 shares are currently held short.
However Pzena Investment Management's short interest can also be evaluated against the total number of Pzena Investment Management shares, or, against the total number of tradable Pzena Investment Management shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Pzena Investment Management's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Pzena Investment Management shares in existence, roughly 0 shares are currently held short) or 0.0094% of the tradable shares (for every 100,000 tradable Pzena Investment Management shares, roughly 9 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Pzena Investment Management.
Find out more about how you can short Pzena Investment Management stock.
Dividend payout ratio: 34.84% of net profits
Recently Pzena Investment Management has paid out, on average, around 34.84% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.15% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Pzena Investment Management shareholders could enjoy a 1.15% return on their shares, in the form of dividend payments. In Pzena Investment Management's case, that would currently equate to about $0.34 per share.
While Pzena Investment Management's payout ratio might seem fairly standard, it's worth remembering that Pzena Investment Management may be investing much of the rest of its net profits in future growth.
Pzena Investment Management's most recent dividend payout was on 19 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 28 July 2021 (the "ex-dividend date").
Over the last 12 months, Pzena Investment Management's shares have ranged in value from as little as $4.6992 up to $12.0977. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Pzena Investment Management's is 1.3593. This would suggest that Pzena Investment Management's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Pzena Investment Management, Inc. is a employee owned investment manager. The firm manages equity mutual funds for its clients. It invests in the public equity markets. The firm provides its services to Individuals, high net worth individuals, investment companies, pooled investment vehicles, charitable organizations, pension and profit sharing plans, state or municipal government entities, charitable organizations, other investment advisers, insurance companies, sovereign wealth funds and foreign official institutions, corporations or other businesses. The firm uses a combination of fundamental analysis to make its investments. The firm employs a combination of in-house and external research to make its investments.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.